Nuveen
NMRA icon

Nuveen’s Neumora Therapeutics NMRA Stock Holding History

Nuveen’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+136,664
New +$260K ﹤0.01% 3588
2025
Q2 		– Sell
-220,970
Closed -$221K – 3356
2025
Q1 		$221K Hold
220,970
– – ﹤0.01% 3113
2024
Q4 		$2.34M Sell
220,970
-4,762
-2% -$57.1K ﹤0.01% 2317
2024
Q3 		$2.98M Hold
225,732
– – ﹤0.01% 2232
2024
Q2 		$2.22M Buy
225,732
+204,983
+988% +$2.12M ﹤0.01% 2332
2024
Q1 		$285K Hold
20,749
– – ﹤0.01% 3112
2023
Q4 		$354K Buy
+20,749
New +$255K ﹤0.01% 3109

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Nuveen's NMRA Position: Q2 2026 in Review

Nuveen opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 136,664 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #3588 among its holdings. This is a return to the name: Nuveen previously reported a position in NMRA as recently as Q1 2025.

Nuveen first reported a position in NMRA in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.98M in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Nuveen held 136,664 shares of Neumora Therapeutics worth $232K as of Q2 2026.
  • Neumora Therapeutics was a new Nuveen position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3588 holding.
  • Nuveen first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • Nuveen's Neumora Therapeutics position peaked at $2.98M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.